Continuum Clinical

Continuum Clinical is a long-established, service-based company in the digital health sector, focused exclusively on solving the critical challenge of patient enrollment and retention in clinical trials. It leverages a combination of creative campaign development, data analytics, and a proprietary engagement platform (MERIS) to deliver fact-based recruitment solutions for clients ranging from startups to top global pharma. Following its 2024 acquisition by the integrated communications and marketing firm Spectrum Science, the company is transitioning its operations and brand to offer a broader suite of services under the Spectrum Science umbrella, aiming to provide greater value and momentum for clinical trial sponsors.

MERIS (Total Engagement Solution for Clinical Trials): A suite of globally compliant software products for patient recruitment, engagement, and retention, supported by integrated creative campaign development.

The market is highly competitive and fragmented. Competitors include the large, global Contract Research Organizations (CROs) that offer patient recruitment as part of their full-service bundles, as well as a multitude of smaller, niche digital recruitment agencies and marketing firms. Continuum's differentiator was its long track record and dedicated platform; post-acquisition, its competitive edge will be its integration within Spectrum Science's broader communications and marketing ecosystem.